Astec LifeSciences Limited — Important, 29-07-2025: Committee Meeting Updates

Astec LifeSciences Limited has finalized its Rights Issue, allotting 26,69,951 new Equity Shares to eligible shareholders and renouncees. Each share was issued at ₹890, comprising a face value of ₹10 and a premium of ₹880. This successful capital raise totals approximately 237.63 Cr, significantly increasing the company's paid-up equity share capital from 1,96,11,710 shares to 2,22,81,661 shares. This move strengthens the company's financial base, providing capital for its business operations and future growth.